| View |
|
BR-669
|
Purified Rabies Vaccine (Vero Cell)
|
Speeda
|
2.5 IU
|
Freeze -Dried Powder for Injection (IM/ID)
|
Vaccine
|
Liaoning Cheng Da Biotechnology Co., Ltd.
|
China
|
Renewal
|
28 December 2018
|
03 February 2029
|
| View |
|
BR-671
|
Human Normal Immunoglobulin(IGIV)
|
Gamma IV
|
50 mg/mL (2.5 g/50 mL)
|
Solution for IV Injection
|
Immuoglobulin
|
Bharat Serums and Vaccines Ltd.
|
India
|
Renewal
|
30 March 2021
|
10 February 2026
|
| View |
|
BR-673
|
Recombinant Human Thrombopoietin
|
Tpiao
|
15,000 IU/mL
|
Solution for Injection (S.C.)
|
Colony-Stimulating Factors
|
Shenyang Sunshine Pharamceutical Co., Ltd.
|
China
|
Automatic Renewal
|
23 September 2022
|
23 September 2027
|
| View |
|
BR-674
|
Live Attenuated Rotavirus Vaccine
|
Rotarix
|
NLT 106.0 CCID 50/1.5 mL
|
Oral Suspension
|
-
|
GlaxoSmithKline Biologicals S.A.
|
Belgium
|
Renewal
|
15 September 2022
|
13 August 2027
|
| View |
|
BR-676
|
Anti-Rabies Serum (Equine)
|
Equirab
|
200 IU/ mL (1,000 IU/ 5mL)
|
Solution for Injection (IM/SC)
|
-
|
Bharat Serums and Vaccines Limited
|
India
|
-
|
30 March 2021
|
06 March 2026
|
| View |
|
BR-680
|
HEPATITIS B VACCINE (RECOMBINANT DNA )
|
Unbranded
|
20mcg/mL
|
Suspension For Injection (IM)
|
VACCINE
|
Serum Institute of India Ltd.
|
India
|
Renewal
|
01 March 2024
|
01 June 2029
|
| View |
BR-689_PI_01.pdf
|
BR-689
|
Tocilizumab
|
Actemra
|
400 mg/ 20 mL
|
Concentrate For Solution For I.V. Infusion
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
Automatic Renewal
|
10 April 2023
|
20 March 2028
|
| View |
BR-690_PI_01.pdf
|
BR-690
|
Tocilizumab
|
Actemra
|
80 mg/ 4 mL
|
Concentrate For Solution For I.V. Infusion
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
Automatic Renewal
|
14 April 2023
|
20 March 2028
|
| View |
BR-691_PI_01.pdf
|
BR-691
|
Tocilizumab
|
Actemra
|
200 mg / 10 mL
|
Concentrate For Solution For I.V. Infusion
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
Automatic Renewal
|
09 April 2023
|
20 March 2028
|
| View |
|
BR-698
|
Filgrastim
|
Recombicyte
|
300mg/0.9mL
|
Solution for Injection (IV/SC)
|
-
|
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
27 April 2021
|
01 July 2026
|
| View |
BR-701_PI_01.pdf
|
BR-701
|
Epoetin Alfa
|
Eprex
|
4000 IU/0.4 mL
|
Solution For Injection (IV/SC)
|
-
|
Cilag AG
|
Switzerland
|
-
|
04 February 2022
|
29 July 2026
|
| View |
BR-702_PI_01.pdf
|
BR-702
|
Epoetin Alfa
|
Eprex
|
10000 IU/mL
|
Solution For Injection (IV/SC)
|
-
|
Cilag AG
|
Switzerland
|
-
|
04 February 2022
|
29 July 2026
|
| View |
BR-704_PI_01.pdf
|
BR-704
|
Epoetin Alfa
|
Eprex
|
40000 IU/mL
|
Solution For Injection (IV/SC)
|
-
|
Cilag AG
|
Switzerland
|
-
|
04 February 2022
|
29 July 2026
|
| View |
|
BR-713
|
Recombinant Human Erythropoietin Alfa
|
Efotin
|
4000 IU/0.8mL
|
Solution For IV Injection
|
-
|
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
|
China
|
-
|
21 April 2021
|
11 February 2026
|
| View |
|
BR-733
|
Human Normal Immunoglobulin (IVIg)
|
Gamunex-C
|
10% (100 mg/mL)
|
Solution for Infusion (IV/SC)
|
-
|
Grifols Therapeutics LLC
|
U.S.A
|
-
|
27 April 2022
|
26 May 2027
|
| View |
|
BR-737
|
Diphtheria and Tetanus Vaccine (Adsorbed)
|
SII TD-VAC
|
Formulation: Each dose (0.5 mL) contains: Diphtheria Toxoid.........<5 Lf 2 2 IU) Tetanus Toxoid................<5 Lf( 40 IU) Adsorbed on Aluminum Phosphate, Al3+.....................< 1.25 mg
|
Suspension for Injection (IM)
|
-
|
Serum Institute of India Pvt. Ltd.
|
India
|
Renewal
|
02 June 2022
|
27 April 2027
|
| View |
|
BR-740
|
Somatropin
|
Genheal
|
4 IU (equivalent to 1.6 mg)
|
Lyophilized Powder for
Injection (IM/SC)
|
-
|
Shanghai United Cell Biotechnology Co., Ltd.
|
China
|
Renewal (Revalidation)
|
17 October 2022
|
26 July 2025
|
| View |
|
BR-744
|
Recombinant Hepatitis B Vaccine
|
Engerix B
|
20 mcg/mL
|
Suspension for Injection (IM)-Thiomersal Free
|
Vaccine
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
Initial (Variation)
|
28 June 2024
|
28 June 2029
|
| View |
|
BR-745
|
Recombinant Hepatitis B Vaccine
|
Engerix B Junior
|
10 mcg/0.5 mL
|
Suspension for Injection
|
Vaccine
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
Initial (Variation)
|
30 October 2024
|
30 October 2029
|
| View |
|
BR-746
|
Filgastrim
|
Leucogen
|
300mcg/mL
|
Solution For Iv/Sc Injection
|
-
|
Center for Molecular Immunology (CIM)
|
Cuba
|
-
|
17 February 2021
|
04 August 2025
|